Intravesical Gem/Doce in Patients With NMIBC | MicrobiomeTrials← Back to trialsNCT05644041
Intravesical Gem/Doce in Patients With NMIBC
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2023-03-01Est. Completion: 2026-10-19
Enrollment target: 31 participants Locations- University of Arizona Cancer Center, Tucson, Arizona, United States
Other microbiome trials you might be interested in
Ganglioneuroblastoma, NodularNeuroblastoma
This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care su…
Birmingham, United StatesEst. completion Dec 31, 2029
Bladder Cancer
Single-arm, open-label window-of-opportunity trial of neoadjuvant Abemaciclib in 20 patients, with tumor tissue obtained…
New York, United StatesEst. completion Jul 2, 2024
Recruiting
NMIBCMIBCMuscle Invasive Bladder Cancer (MIBC)Non Muscle Invasive Bladder Cancer
This study aims to better understand how treatment choices impact outcomes for patients with intermediate- and high-risk…
Dallas, United StatesEst. completion May 2032